The latest biotech news

News and Trends 29 Nov 2017

Belgian Firm Raises €80M for Rapid Infection and Cancer Tests

Biocartis is aiming to raise funds through a private placement of shares in order to support sales and further development of its rapid cancer tests. Based in Mechelen, Belgium, Biocartis focuses on developing fast, easy-to-use diagnostics. In order to boost its molecular diagnostics technology, the company launched a private equity placement of shares on Euronext […]

November 29, 2017 - 1 minutemin - By Clara Rodríguez Fernández

News and Trends 29 Nov 2017

Merck and Pfizer’s Checkpoint Inhibitor Fails to Treat Gastric Cancer

Avelumab, marketed as Bavencio by Pfizer and Merck, has failed to show better efficacy than chemotherapy in a Phase III trial with gastric cancer patients. Merck (the German one) and Pfizer joined the checkpoint inhibitor club earlier this year with the approval of Bavencio (avelumab) in both the US and Europe. Looking to keep expanding the […]

November 29, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 29 Nov 2017

Guilt-free and Odour-free: French Biotech Fights for Green Cosmetics

Global Bioenergies has produced the first batch of its sustainable isobutene, which L’Oréal will use to produce environmentally friendly hairspray and deodorant. Global Bioenergies has produced the first batch of its sustainable biochemical for L’Oréal. The French biotech hopes to support the shift away from fossil fuels that could change the world. It has taken its first step […]

November 29, 2017 - 3 minutesmins - By Alex Dale

News and Trends 29 Nov 2017

One Mouse with All-Human Antibodies

Monoclonal antibodies have long been the focus of research surrounding drug development against inflammatory diseases and cancer. For decades, researchers have had to travel along a strenuous path to get to where we are now. After monoclonal antibodies (mAb) were discovered in the first half of the 20th century, researchers quickly understood that animals, such […]

November 29, 2017 - 6 minutesmins - By External Contributor

News and Trends 28 Nov 2017

A Treatment for Sudden Deafness Fails in Phase III

Auris Medical’s treatment for sudden deafness has failed to meet its efficacy endpoint, leading the company to terminate a second trial early. Based in Zug, Switzerland, Auris Medical is developing what could be the first treatments for inner ear disorders such as hearing loss, tinnitus, and vertigo. But today, the company suffered a setback. Its lead […]

November 28, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 28 Nov 2017

Cheap DNA Tests for Everyone! Italian Biotech Launches €149 Kit

Dante Labs has developed the first DNA tests available in Europe, which will allow the public to test their health and wellbeing from the comfort of their own homes. Dante Labs hopes to transform genetics. The biotech wants to develop accessible genomic testing, giving people the knowledge and information they need to live long, healthy lives. Yesterday, the […]

November 28, 2017 - 3 minutesmins - By Alex Dale

News and Trends 28 Nov 2017

New Gene Therapy for Parkinson’s will be Developed in the UK

Synpromics and UCL will collaborate to develop a gene therapy to treat Parkinson’s disease that only targets specific neurons involved in the disease. Synpromics, based in Edinburgh, Scotland, is a company focusing on gene control. The biotech has decided to put its technology to use for the development of a gene therapy for Parkinson’s in […]

November 28, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 28 Nov 2017

The Link Between Type 2 Diabetes and Obesity may have Finally been Uncovered

Researchers at the Université de Genève have unravelled the cellular and molecular mechanisms linking obesity and insulin resistance. We have long known about a link between obesity and type 2 diabetes, but discovering the underlying mechanisms has proved difficult. A group of researchers at the Université de Genève, Switzerland, may have found a protein that links changes […]

November 28, 2017 - 3 minutesmins - By Alex Dale

News and Trends 28 Nov 2017

Dutch Cancer Nanoparticles Get €2.5M from the EU to Enter Phase II

The EU has awarded Cristal Therapeutics a grant from its Horizon 2020 program. This will support the development of its cancer nanoparticles through Phase II. Horizon 2020 is the biggest EU Research and Innovation program with close to €80B already handed out to help exciting science towards the market. Cristal Therapeutics is a biopharmaceutical company developing targeted nanomedicines for cancer and […]

November 28, 2017 - 2 minutesmins - By Alex Dale

News and Trends 27 Nov 2017

Picking the Perfect Time to Strike: How to Stop HIV in its Tracks

In the early stages of infection, the immune system might be able to stop HIV. Austrian researchers have taken a closer look to see what can be done before it’s too late. There has been no shortage of research to find an effective treatment or cure for HIV/AIDS, which affects over 36 million people. Austrian researchers at the […]

November 27, 2017 - 3 minutesmins - By Alex Dale

DNA Tetris Bixels Cell Free Technologies

News and Trends 27 Nov 2017

You Can Now Play DNA Tetris Thanks to This Irish Startup

How cool would it be to program DNA at home to make gifs or play Tetris? Well, this device will soon let you do just that. Cell-Free Technologies wants to take synthetic biology out of the lab and into our homes. This startup based in Cork, Ireland, takes the molecular machinery that cells use to read […]

November 27, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 27 Nov 2017

NASH Leader Signs Up for EU Project to Fight Deadly Liver Disease

Update 27/11/17: Genfit, the leader in the fight against NASH, has joined the LITMUS study. The company will share its experience and resources with the EU collaboration by contributing samples from its RESOLVE-IT clinical study. Genfit will co-lead two projects in patient recruitment and specialized biomarker assays, focusing on genetics and miRNA. Originally published: 23/11/17 […]

November 27, 2017 - 3 minutesmins - By Alex Dale

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Belgian Firm Raises €80M for Rapid Infection and Cancer Tests

Merck and Pfizer’s Checkpoint Inhibitor Fails to Treat Gastric Cancer

Guilt-free and Odour-free: French Biotech Fights for Green Cosmetics

One Mouse with All-Human Antibodies

A Treatment for Sudden Deafness Fails in Phase III

Cheap DNA Tests for Everyone! Italian Biotech Launches €149 Kit

New Gene Therapy for Parkinson’s will be Developed in the UK

The Link Between Type 2 Diabetes and Obesity may have Finally been Uncovered

Dutch Cancer Nanoparticles Get €2.5M from the EU to Enter Phase II

Picking the Perfect Time to Strike: How to Stop HIV in its Tracks

You Can Now Play DNA Tetris Thanks to This Irish Startup

NASH Leader Signs Up for EU Project to Fight Deadly Liver Disease

Subscribe to our newsletter to get the latest biotech news!